FDA Inspection 843254 — LANXESS Corporation

LANXESS Corporation — FEI 3022820

The FDA completed an inspection of LANXESS Corporation on Aug 2, 2013 in Kalama, WA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Aug 2, 2013
Fiscal Year
2013
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Kalama, WA (United States)